Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramona Mayer

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Breast Journal|August 30, 2002
Radiation-induced osteosarcoma of the chest wallRamona Mayer, Christian Aigner, Heidi Stranzl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2003
Analysis of competing risk parameters in irradiated prostate cancer patientsRamona Mayer, Karl Pummer, Franz Quehenberger, et al.
Acta Medica Austriaca|February 1, 2003
Palliative treatment of unresectable bile duct tumoursRamona Mayer, Heidi Stranzl, Ulrike Prettenhofer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
The role of radiation therapy after incomplete resection of penile cancerTanja Langsenlehner, Ramona Mayer, Franz Quehenberger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2005
Lymphatic fistulas: obliteration by low-dose radiotherapyRamona Mayer, Peter Sminia, William H McBride, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancerTanja Langsenlehner, Uwe Langsenlehner, Wilfried Renner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
The Prostate|January 1, 2008
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastasesTanja Langsenlehner, Uwe Langsenlehner, Wilfried Renner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2014
Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment optionUlrike Mock, Dietmar Georg, Lukas Sölkner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2007
Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcomeTanja Langsenlehner, Claudia Stiegler, Franz Quehenberger, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Breast Journal|August 30, 2002
Radiation-induced osteosarcoma of the chest wallRamona Mayer, Christian Aigner, Heidi Stranzl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2003
Analysis of competing risk parameters in irradiated prostate cancer patientsRamona Mayer, Karl Pummer, Franz Quehenberger, et al.
Acta Medica Austriaca|February 1, 2003
Palliative treatment of unresectable bile duct tumoursRamona Mayer, Heidi Stranzl, Ulrike Prettenhofer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
The role of radiation therapy after incomplete resection of penile cancerTanja Langsenlehner, Ramona Mayer, Franz Quehenberger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2005
Lymphatic fistulas: obliteration by low-dose radiotherapyRamona Mayer, Peter Sminia, William H McBride, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancerTanja Langsenlehner, Uwe Langsenlehner, Wilfried Renner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based studyTanja Eder, Ramona Mayer, Uwe Langsenlehner, et al.
The Prostate|January 1, 2008
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastasesTanja Langsenlehner, Uwe Langsenlehner, Wilfried Renner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2014
Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment optionUlrike Mock, Dietmar Georg, Lukas Sölkner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2007
Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcomeTanja Langsenlehner, Claudia Stiegler, Franz Quehenberger, et al.
Pageof 3